GPT and metabolic syndrome: When the ratio of ALT/AST is elevated in obese patients, it suggests the possibility of metabolic syndrome, extensive liver damage, and poor prognosis (Kim et al., 2006; Carrillo-Iregui et al., 2010; Uemura et al., 2014).